SCHEMBL23409668

SCHEMBL23409668

C[C@H]1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.44
PTPN1 P18031 4/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 2/20 0.40
CYP2C19 P33261 2/20 0.40
CDC25A P30304 1/20 0.37
DUSP3 P51452 1/20 0.37
IDO1 P14902 1/20 0.37
CYP19A1 P11511 2/20 0.36
PTPN2 P17706 1/20 0.35
TRPA1 O75762 2/20 0.34
NR1H4 Q96RI1 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332539 1.00 CETP (0.44) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL30041044 0.93 PTPN1 (0.48) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL21796032 0.80 IDO1 (0.45) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL23597397 0.80 IDO1 (0.45) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL29501287 0.79 CETP (0.53) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL9277186 0.77 CETP (0.46) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL15886566 0.76 CETP (0.48) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL19228575 0.76 CETP (0.48) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL24590627 0.75 CETP (0.53) CETPPTPN1ALDH1A1CYP3A4CYP2C9
SCHEMBL16010791 0.73 PTPN1 (0.41) CETPPTPN1ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612653-B2 Polypeptides for producing albicanol and/or drimenol compounds FIRMENICH SA (CH) 2026-04-28 US disclosed
US-20240376502-A1 NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS FIRMENICH SA (CH) 2024-11-14 US disclosed
EP-4013862-A2 NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS Firmenich SA (CH) 2022-06-22 EP disclosed
CN-113853432-A Novel polypeptides for producing orexin and/or drimenol compounds 弗门尼舍有限公司 2021-12-28 CN disclosed
WO-2021105236-A2 NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS FIRMENICH SA (CH) 2021-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612653-B2 Polypeptides for producing albicanol and/or drimenol compounds FDPS, DHPS, HDHD5 CETP 623/4885PTPN1 2711/4885ALDH1A1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.